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Abstract 1 
 2 
Omega-3 fatty acids are associated with better cardiovascular and cognitive health. However, the 3 
concentration of EPA, DPA and DHA in different plasma lipid pools differs and factors influencing 4 
this heterogeneity are poorly understood. Our aim was to evaluate the association of oily fish intake, 5 
sex, age, BMI and APOE genotype with concentrations of EPA, DPA and DHA in plasma PC, 6 
NEFAs, CEs and TGs. Healthy adults (148 male, 158 female, age 20-71 years) were recruited 7 
according to APOE genotype, sex and age. Fatty acid composition was determined by gas 8 
chromatography. Oily fish intake was positively associated with EPA in PC, CEs and TGs, DPA in 9 
TGs, and DHA in all fractions (P < 0.008). There was a positive association between age and EPA 10 
in PC, CEs and TGs, DPA in NEFAs and CEs, and DHA in PC and CEs (P < 0.034). DPA was 11 
higher in TGs in males than females (P < 0.001). There was a positive association between BMI 12 
and DPA and DHA in TGs (P < 0.006 and 0.02, respectively). APOE genotype*sex interactions 13 
were observed: the APOE4 allele associated with higher EPA in males (P = 0.002), and there was 14 
also evidence for higher DPA and DHA (P < 0.032). In conclusion, EPA, DPA and DHA in plasma 15 
lipids are associated with oily fish intake, sex, age, BMI, and APOE genotype. Such insights may be 16 
used to better understand the link between plasma fatty acid profiles and dietary exposure and may 17 
influence intake recommendations across population subgroups.  18 
 19 
 20 
 21 
 22 
Keywords: apolipoprotein E (APOE) genotype; oily fish intake; omega 3 status; n-3 long chain 23 
polyunsaturated fatty acids; eicosapentaenoic acid (EPA); docosahexaenoic acid (DHA); fatty acid 24 
status; blood lipids.  25 
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Introduction 26 
There is convincing evidence that higher intakes of the marine long chain n-3 PUFAs (LC n-27 
3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are beneficial to 28 
cardiovascular and cognitive health, acting through a number of biological mechanisms, and that 29 
the concentration of EPA and DHA present in blood and tissue lipids is correlated positively with 30 
these effects 1-5. Oily fish are a good source of EPA and DHA; therefore, national and international 31 
authorities recommend regular consumption of oily fish such as salmon, mackerel, kippers, 32 
sardines, herring, trout and fresh tuna, in order to provide approximately 500 mg EPA+DHA per 33 
day 6, with higher intakes of LC n-3 PUFAs recommended for those with diagnosed cardiovascular 34 
disease 7. However, the associations between intake and blood and tissue status, and therefore 35 
physiological benefits, are highly variable 8, and the factors influencing this heterogeneity are not 36 
well understood. A greater knowledge of determinants of LC n-3 PUFA status could lead to the 37 
development of more robust, and perhaps subgroup specific, recommendations for EPA and DHA 38 
intake.  39 
In addition to intake of the specific LC n-3 PUFAs and their precursors, the heterogeneity in 40 
habitual EPA, docosapentaenoic acid (DPA) and DHA concentrations may be influenced by 41 
differences in fatty acid metabolism between sexes; females are reported to synthesise EPA, DPA 42 
and DHA from shorter chain n-3 fatty acids more readily than males 9-13. Lipid metabolism alters 43 
with age and becomes dysregulated in obesity, and EPA and DHA concentrations have been 44 
reported to be affected by increasing BMI 12 14 as well as with age 10-12. Apolipoprotein E (APOE) 45 
genotype is associated with altered lipid metabolism and transport, with differential responses in 46 
APOE4 carriers relative to non-carrier groups 12 14. Recent reports highlight the importance of 47 
APOE genotype in the response of EPA and DHA to supplementation and have indicated 48 
interactions between genotype and BMI 14. In addition, the concentrations of LC n-3 PUFAs in 49 
individual lipid pools within blood (and in other tissues) differs 15. However, despite these insights 50 
from the published literature, the influence of oily fish intake, along with sex, age, BMI and APOE 51 
genotype on EPA, DPA and DHA concentrations in different plasma pools has not been examined 52 
systematically. Using samples from the FINGEN study 4, where participants were prospectively 53 
recruited based on a number of these variables (sex, age, and APOE genotype), we have conducted 54 
such an analysis in a large number of participants to evaluate the independent and interactive impact 55 
of a number of potential determinants (oily fish intake, sex, age, BMI and APOE genotype) on EPA, 56 
DPA and DHA concentrations in the main plasma lipid fractions.  57 
 58 
Participants and methods 59 
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The FINGEN study was a multi-centre trial conducted at the Universities of Glasgow, 60 
Newcastle, Reading and Southampton in the United Kingdom. Three hundred and twelve 61 
participants were recruited prospectively on the basis of APOE genotype (87 were APOE2 62 
homozygotes or APOE2/APOE3, 111 were homozygous for APOE3, and 114 were APOE4/APOE3 63 
or APOE4 homozygotes), sex (149 male and 163 female) and age (20 to 71 years, with 64 
approximately equal numbers in each of the 5 decades) 4. Data from 306 participants were included 65 
in the current analysis, with the numbers in each subgroup detailed in Supplemental Table 1 and 66 
Supplemental Table 2. Exclusion criteria included: diagnosed endocrine dysfunction including 67 
diabetes or fasting glucose concentration > 6.5 mmol/L, myocardial infarction in the previous 2 68 
years, the use of medication that may interfere with lipid metabolism, fasting total cholesterol of > 69 
8.0 mmol/L or TG of > 3.0 mmol/L, a BMI of < 18.5 or > 36.0 kg/m2, or currently following a 70 
weight loss diet. Individuals taking n-3 fatty acid supplements were also excluded. The study was 71 
approved by the research ethics committee at each of the participating centres and written informed 72 
consent was obtained from all subjects prior to participation.  73 
 74 
Study design  75 
The FINGEN study was a randomised double blind, placebo controlled, crossover study 76 
testing two doses of fish oil compared with placebo 4. Here we evaluate the association of oily fish 77 
intake, sex, age, BMI and APOE genotype with fasting concentrations of EPA, DPA and DHA in 78 
plasma phosphatidylcholine (PC), non-esterified fatty acids (NEFAs), cholesteryl esters (CEs) and 79 
triacylglycerols (TGs) at baseline, prior to intervention. Habitual oily fish intake was estimated by 80 
food frequency questionnaire (FFQ), using self-reported portions completed at baseline. Oily fish 81 
was defined as salmon, herring, mackerel, fresh tuna, sardines, kippers, and trout.  82 
 83 
Fatty acid analysis 84 
The fatty acid composition of the plasma fractions was determined by gas chromatography. 85 
Dipentadecanoyl PC, heneicosanoic acid, cholesteryl heptadecanoate and tripentadecanoin internal 86 
standards were added to the plasma. Total plasma lipid was extracted using chloroform: methanol 87 
(2:1, v/v) containing butylated hydroxytoluene (50 mg/L) as described by Folch et al 16, and PC, 88 
NEFA, CE and TG fractions were separated and isolated by solid phase extraction on aminopropyl 89 
silica cartridges. CEs and TGs were eluted in a combined fraction with the addition of chloroform. 90 
PC was then eluted from the cartridge with the addition of chloroform: methanol (60:40 v/v). 91 
NEFAs were eluted from the cartridge with the addition of chloroform: methanol: glacial acetic acid 92 
(100:2:2 v/v). CEs and TGs were separated on a hexane primed aminopropyl silica cartridge with 93 
the addition of hexane to elute CEs, and the addition of hexane: methanol: ethyl acetate (100:5:5 94 
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v/v/v) to elute TGs. The fatty acids within the resulting lipid fractions were methylated by the 95 
addition of methanol in 2% (v/v) sulphuric acid at 50°C for 2 hours to produce fatty acid methyl 96 
esters (FAMEs) 17. FAMEs were extracted into hexane and separated in a BPX-70 fused silica 97 
capillary column (30 m × 0·25 mm × 25 μm; SGE Analytical Science, United Kingdom) using an 98 
Agilent 6890 series gas chromatograph equipped with flame ionisation detection (Agilent 99 
Technologies, California, United States). The FAMEs were identified by comparison with retention 100 
times of 37 FAME and menhaden oil standards run alongside the samples, and quantified with the 101 
use of the internal standards using ChemStation software (Agilent Technologies, California, United 102 
States) and Microsoft Excel (Microsoft Corporation, Washington, United States). Fatty acid 103 
composition data are expressed as absolute concentrations (µg/ml plasma) and as relative 104 
concentrations (g/100 g total fatty acid (%)). 105 
 106 
Statistics 107 
Here we report baseline data obtained as part of the previous FINGEN trial4. Characteristics 108 
for participants included in the baseline analysis are detailed in Supplemental Table 1 and 109 
Supplemental Table 2.  110 
Results for the relative (%) and absolute concentrations (µg/ml) of fatty acids are reported 111 
for 303 to 306 and 292 to 306 participants in the four plasma lipid fractions. Data were checked for 112 
normality by plotting distributions of residuals obtained from general linear model (GLM) analysis 113 
of the data, and were analysed appropriately with a univariate GLM following log10 transformation. 114 
All variables were included in the univariate model with individual associations analysed using 115 
‘main effects’ and interaction between age and BMI, age and fish intake, and sex and APOE 116 
analysed using ‘interaction’ analysis options within the model. P values were corrected for multiple 117 
analyses using Bonferroni post hoc analysis resulting in a significance value of P = 0.006 for whole 118 
group analysis and P = 0.008 for analyses where males and females were analysed separately. All 119 
statistical analyses were conducted using SPSS software (version 21; SPSS Inc, Chicago, IL). 120 
Statistical significance was defined as P < 0.05. Results are expressed as mean ± SEM or median 121 
(25th, 75th percentiles).  122 
 123 
Results  124 
The group (n = 306) mean age and BMI was 45.1 ± 0.7 y and 25.2 ± 0.2 kg/m2, respectively.   125 
 126 
Male and female participants were well matched for age, but males had a significantly higher 127 
average BMI (P < 0.001, Supplemental Table 1 and Supplemental Table 2). There were no sex 128 
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differences in the proportion of total dietary energy consumed from fat, saturated fat (SFA), 129 
monounsaturated fat (MUFA) or polyunsaturated fat (PUFA) (data not shown). The average oily 130 
fish intake was 1.0 portion per week with no association of sex with oily fish intake. 131 
 132 
For all three LC n-3 PUFAs, the greatest concentrations were evident in the PC fraction, with 133 
median absolute concentrations (µg/ml) of 15.1, 11.9 and 44.1 for EPA, DPA and DHA, 134 
respectively. The median values for EPA, DPA and DHA for the whole group and P values for the 135 
association of oily fish intake, sex, age, BMI and APOE with the plasma concentrations of these 136 
fatty acids in the four lipid fractions are presented in Table 1. The data according to oily fish intake 137 
are shown in Supplemental Figures 1-4, while data according to age and BMI are shown in Table 138 
2 and Supplemental Tables 3-5, and those according to APOE genotype*sex in Figures 1-3. 139 
 140 
Plasma EPA, DPA and DHA in the group as a whole 141 
 142 
EPA: The concentration of EPA in plasma CEs and TGs was positively associated with oily fish 143 
intake (P < 0.004), with evidence for positive association in plasma PC also (P = 0.018) (Table 1). 144 
There was evidence for a positive association between EPA and age in plasma PC, CE’s and TGs (P 145 
= 0.021, 0.019, and 0.034 respectively) and for the concentration of EPA in CEs to differ by sex (P 146 
= 0.055), (Table 2). A higher concentration of EPA in CEs was observed in males (Table 2), and 147 
the concentration of EPA in TGs was associated with an APOE*sex interaction (P = 0.044, data not 148 
shown).  149 
 150 
DPA: The concentration of DPA was positively associated with oily fish intake in plasma TGs (P = 151 
0.006), with evidence for positive association in plasma PC also (P = 0.022) (Table 1). DPA in TGs 152 
was positively associated with BMI (P = 0.006) (Table 1), and there was evidence for the positive 153 
association of DPA in NEFAs and CEs with age (P = 0.031 and 0.007 respectively, Table 1). The 154 
concentration of DPA significantly differed by sex with a higher concentration of DPA observed in 155 
plasma TGs in males (P <0.001), with a trend in PC also (P 0.031) (Table 1). There was also a 156 
significant APOE*sex interaction for the concentration of DPA in CEs (P < 0.005, data not shown). 157 
(Table 1), 158 
 159 
DHA: The concentration of DHA in all plasma lipid fractions was positively associated with oily 160 
fish intake (P < 0.001). There was evidence for a positive association of DHA in TGs with BMI (P 161 
= 0.020) (Table 1) and with age in PC, CEs and TGs (P = 0.037, 0.039, and 0.050 respectively, 162 
Table 1).  163 
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 164 
Overall in PC, NEFAs, CEs, and TGs, the highest oily fish consumers (2+ portions of oily fish per 165 
week) had 55%, 42%, 52% and 119% higher EPA+DHA, respectively, compared with those 166 
reporting no oily fish intake (Supplemental Figure 4).  167 
 168 
Due to the significant evidence of sex and APOE*sex interactions, subgroup analysis was 169 
performed in males and females separately. 170 
 171 
Subgroup analysis of plasma EPA, DPA and DHA according to sex 172 
 173 
Significance data (P) are reported for EPA, DPA and DHA in Table 2 and median data are reported 174 
for EPA, DPA and DHA in Supplemental Tables 3, 4, and 5 respectively. 175 
  176 
EPA (Table 2, Supplemental Table 3): The concentration of EPA in plasma TGs was positively 177 
associated with oily fish intake in both males and females (P < 0.008), while the concentration of 178 
EPA in PC was positively associated with oily fish intake in females only (P < 0.004. EPA 179 
concentration in TGs was positively associated with age and BMI in females (P = 0.006), while 180 
EPA in TGs differed by APOE genotype in males (P = 0.002), with evidence for this in CEs also (P 181 
= 0.019), (Figure 1). A greater concentration of EPA in TGs was observed in male APOE4 carriers 182 
(P = 0.002) with evidence for this in PC and CEs also (P = 0.019 and 0.053 respectively), (Figure 183 
1).   184 
 185 
DPA (Table 2, Supplemental Table 4): The concentration of DPA in plasma TGs was positively 186 
associated with oily fish intake in females (P = 0.008). There was evidence for DPA concentration 187 
in PC to differ with APOE genotype in males (P < 0.053, Figure 2) with further analysis revealing 188 
evidence for higher concentrations of DPA in PC in APOE4 allele carriers (P = 0.032, Figure 2).  189 
 190 
DHA (Table 2, Supplemental Table 5): The concentration of DHA was positively associated with 191 
oily fish intake in plasma PC, NEFAs, and TGs in females (P < 0.002) and plasma PC in males (P < 192 
0.003), (Table 2). There was evidence for DHA in plasma NEFAs to be associated with BMI in 193 
females (P = 0.010, Table 2), and for DHA in CEs to differ by APOE genotype in males. Further 194 
analysis revealed evidence for a higher concentration of DHA in CEs in APOE4 carriers (P = 0.021, 195 
Figure 3). 196 
 197 
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Discussion 198 
EPA and DHA have been widely reported for their beneficial effects on cardiovascular and 199 
cognitive health 1-4 18 but a high level of variation in associations between intake and blood and 200 
tissue status has been observed 8. The current analysis aimed to identify factors associated with 201 
concentrations of EPA, DPA and DHA in major lipid fractions in plasma from individuals 202 
consuming their usual diet in order to identify sources of variation in these concentrations. 203 
Identification of the contribution that oily fish intake, sex, age, BMI and APOE genotype make to 204 
EPA, DPA and DHA status is important for two reasons. First it will highlight the sources of the 205 
heterogeneity in status of these fatty acids, contributing to a better understanding of the use of fatty 206 
acid profiles as a measure of dietary intake amongst different population subgroups. Secondly, it 207 
may allow the development of sub-group specific recommendations for LC n-3 PUFA intake.  208 
The current study reports associations for multiple confounding variables with the relative 209 
and absolute concentrations of EPA, DPA and DHA in different plasma lipids. The relative 210 
concentration allows investigation of LC n-3 PUFA concentrations in relation to all other fatty acids 211 
within the plasma pool (% unit changes), while the absolute concentration allows investigation of 212 
µg/ml unit changes in LC n-3 PUFAs independently of any other fatty acid within the plasma pool. 213 
Both ways of expressing the data are useful and informative and both are used in the literature in the 214 
field. The absolute concentration of a fatty acid within any plasma lipid fraction will be influenced 215 
by the total concentration of that fraction. The absolute concentration of a particular fatty acid may 216 
differ between individuals or between sub-groups while the relative concentration of that fatty acid 217 
may not be different between those individuals or sub-groups. Conversely, the relative 218 
concentration could be different but the absolute concentration may not be. Plasma lipids are 219 
involved in transport of fatty acids between tissues where they have different actions depending 220 
upon their structure. Hence, the absolute concentration of a fatty acid in a plasma lipid reflects the 221 
exposure of tissues to that fatty acid and hence is likely to be a meaningful way of reporting the 222 
fatty acid. Conversely, fatty acids often compete with one another for metabolism or for function 223 
and hence the relative concentration of each fatty acid (i.e. %) is also likely to be meaningful.  224 
Quantitatively, PC is the main plasma LC n-3 PUFA pool and the current study reports a 225 
greater relative concentration of EPA+DHA in plasma PC (Supplemental Figure 4) in individuals 226 
consuming 2+ portions of oily fish a week compared to those who reported not consuming oily fish, 227 
as well as positive associations between EPA, DPA and DHA in other plasma lipid fractions and 228 
oily fish intake. Positive associations for oily fish intake and EPA and DHA are reported for plasma 229 
phospholipids 19-21 which are confirmed by data from the current analysis which shows 55% higher 230 
EPA+DHA in plasma PC in those consuming two portions of oily fish (each 150 g) per week 231 
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compared with those reporting no oily fish consumption. Two portions of oily fish supply about 4-5 232 
g of EPA+DHA per week, equivalent to 600-700 mg per day22 23. Previous studies report 233 
comparable increases of 81% in plasma phospholipid EPA+DHA, and 8.8 µg/ml and 8.5 µg/ml in 234 
total plasma EPA and DHA respectively following 16 week consumption of oily fish providing 485 235 
mg EPA+DHA per day 20 and 6 week consumption of oily fish providing 927 mg EPA+DHA per 236 
day, respectively21. Overall, the findings of the current analysis support existing reports that oily 237 
fish intake is associated with, and at a population level is the main determinant of, LC n-3 PUFAs 238 
in all major blood lipid pools, which may therefore be used as biomarkers of oily fish intake 4 19 24 239 
25. Our analysis does not clearly indicate which plasma lipid fraction would best reflect dietary 240 
intake of EPA and DHA, since, in general all four plasma lipid fractions showed dose-dependent 241 
increases in EPA and DHA concentration (both absolute and relative) with increasing frequency of 242 
oily fish consumption. 243 
There is some evidence that age influences the concentration of EPA and DHA in various 244 
plasma fatty acid fractions, 10 which has been attributed in part to higher habitual fish intake with 245 
increasing age. Oily fish intake was controlled for in the current statistical analysis, allowing clearer 246 
attribution of any observed associations of age with EPA, DPA and DHA concentrations to altered 247 
metabolism and not to dietary differences in intakes of oily fish. Any influence of APOE group 248 
distribution was also ruled out as, despite a greater number of individuals aged 50-59 yr being 249 
included in the current analysis, there was no significant difference in the distribution of APO E2, 250 
E3 and E4 genotypes between age groups (data not shown). A 28 d stable isotope tracer study in 251 
young (mean age 27 y) vs older (mean age 77 y) adults reported a 1-2 fold greater enrichment of 252 
13C–DHA in plasma phospholipids and CEs in the older age group, suggesting a medium term age-253 
related difference in DHA homeostasis associated with accumulation of DHA in the circulation in 254 
older people 26. The findings of the current analysis support reports of increased plasma DHA with 255 
increasing age 11 27 28 and we further also report positive associations between age and EPA and 256 
DPA, suggesting LC n-3 PUFAs accumulate in plasma pools during ageing. However, this may in 257 
part be due to an increase in circulating cholesterol and CE with age (Table 3). Evidence of positive 258 
associations of plasma total cholesterol with age dates back to the late 1970s 29, and these have been 259 
reported in both males and females 30. Increased circulating LDL (Table 3) may be reflected in 260 
higher absolute total PC and CE concentrations with age (P = 0.008 and 0.018, age 20-29 vs 60+ yr 261 
for PC and CE respectively, data not shown) and we observed that total cholesterol (TC) and LDL-262 
cholesterol (LDLC) concentrations were significantly positively correlated with LC n-3 PUFA 263 
concentrations in PC (TC, P = <0.001, 0.003, 0.027; LDLC P = <0.001, <0.001, 0.003, absolute 264 
EPA, DPA and DHA respectively, data not shown), and that TC, LDLC and high density 265 
lipoprotein cholesterol (HDLC) concentrations were positively correlated with LC n-3 PUFA in 266 
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CEs (TC, P = <0.001, 0.002 absolute EPA and DHA respectively, LDL, P = <0.001, 0.046, 0.055 267 
absolute EPA, relative DPA and DHA respectively, HDLC, P = 0.046 relative DPA, data not 268 
shown). These data suggest CE levels may play a significant role in the association of age with LC 269 
n-3 PUFAs reported in this analysis. 270 
Insulin has a role in the regulation of genes involved in whole body lipid homeostasis 271 
including in the  removal of lipids from the circulation31; in cases of insulin resistance, such 272 
removal can be compromised. The occurrence of insulin resistance is reported to rise with 273 
increasing age and BMl and despite individuals with diabetes or a fasting glucose concentration > 274 
6.5 mmol/L being excluded from the current analysis, differences in fasting glucose were still 275 
evident between age and BMI groups (glucose positively correlated with age and BMI; P <0.001 276 
both, data not shown). Thus, insulin resistance may contribute to the higher EPA and DPA 277 
concentrations in plasma lipid pools observed with increasing age and BMI.  278 
Increasing body fatness and obesity influence many aspects of fatty acid and lipid 279 
metabolism and contribute to disease states such as hypertriglyceridemia, diabetes, and fatty liver 280 
disease 12 32; loss of insulin sensitivity with increasing adiposity results in adipose tissue lipolysis 281 
and associated higher plasma NEFA concentrations 32-34. In the current analysis, there was no 282 
correlation between total NEFA concentrations and BMI (data not shown); however, significant, but 283 
complex, associations between BMI and LC n-3 PUFAs were evident in plasma TGs, with an 284 
overall trend towards lower relative concentrations of EPA and DHA with increasing BMI, which is 285 
consistent with previous observations 33 35. Increased β-oxidation of DHA associated with increased 286 
BMI may in part explain lower proportions of LC n-3 PUFAs in TGs 36 although altered TG 287 
synthesis and/or selective tissue uptake and partitioning in obesity may also be involved. We 288 
observed no association of BMI with absolute plasma concentrations of LC n-3 PUFAs and suggest 289 
the lower relative concentrations (i.e., %) of EPA and DHA are likely to be offset by increases in 290 
total TG concentrations with increasing BMI.  291 
The proteins encoded by the APOE gene play a major role in the transport and metabolism 292 
of lipids via interaction with LDL receptors (LDLRs). Two common polymorphisms (rs7412 and 293 
rs429358) of the APOE gene in humans result in three protein isoforms, APOE2, E3 and E4. 294 
APOE2 and APOE3 are found in the circulation mainly on high density lipoproteins (HDLs) 295 
whereas APOE4 is found preferentially on very low density lipoproteins (VLDLs) with lower 296 
concentrations residing on HDLs 37. The APOE4 allele has been associated with reduced longevity 297 
38, and enhanced risk of cardiovascular disease 39 and Alzheimer’s disease 40. Although centrally 298 
involved in fatty acid transport and handling in plasma and tissues (and in particular within the 299 
brain where APOE is almost the only apolipoprotein present), the impact of APOE genotype on 300 
these processes, and the contribution of dysregulated EPA and DHA metabolism to disease risk is 301 
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unknown. However, 13C–DHA labelling studies provide evidence that DHA metabolism is 302 
disturbed in those who are APOE4 carriers 41.  303 
In the current analysis, APOE4 carriers had significantly higher concentrations of TC and 304 
HDLC, and lower concentrations of LDLC (Table 3); however, sex*APOE genotype interactions 305 
were evident and in male APOE4 carriers we observed to have significantly higher concentrations 306 
of LDLC as well as of total CEs (data not shown). One advantage of investigating associations in 307 
individual plasma lipid classes as opposed to total lipid is that possible effects of APOE and 308 
lipoprotein transport and metabolism may be more easily identified. If the associations between 309 
APOE and LC n-3 PUFAs are seen to occur in lipid pools which are predominantly related to LDL 310 
and VLDL particles, they may reflect the dysregulation in lipoprotein handling in people with the 311 
E4 allele. However, if the associations between LC n-3 PUFA and APOE genotype are seen to 312 
occur across all lipid pools, they may be indicative of alternative mechanisms. Further subgroup 313 
analysis indicated higher EPA, DPA and DHA concentrations in CEs, EPA and DPA in PC, and 314 
EPA in TGs in male APOE4 carriers relative to the non-carrier groups. The higher EPA and DHA 315 
may reflect higher overall CE and PC concentrations; however, the lack of association between 316 
APOE genotype and fatty acid concentrations in females is suggestive of a sex specific association 317 
independent of CE and PC metabolism.  318 
Interestingly, we have previously reported APOE genotype mediated differences in the 319 
response of plasma EPA and DHA to a fish oil supplement given over eight weeks in males, with 320 
lower enrichment in total lipid and phospholipid EPA and DHA in APOE4 carriers relative to the 321 
wild-type APOE3/E3 genotype, but only in overweight participants 14. The aetiology of these 322 
associations with LC n-3 PUFA metabolism is currently unknown. As with the association with 323 
age, higher plasma LC n-3 PUFAs in APOE4 carriers may reflect reduced tissue uptake and DHA 324 
accumulating in the circulation. Although lower overall concentrations of APOE were observed in 325 
APOE4 carriers (data not shown) no difference in plasma APOE concentrations were evident 326 
between sexes, which potentially could have contributed to the differential associations of APOE 327 
genotype with EPA, DPA and DHA concentrations. The preferential binding of VLDL by APOE4 328 
and possible associations of APOE genotype with PC and CE synthesis and cellular uptake of EPA 329 
and DHA via the LDLR family, LDLR concentrations and specific LC PUFA transporters such as 330 
the MFSD2A transporter in the brain 42 may be involved, and are worthy of future investigations. 331 
Associations between sex and the activity of these transporters and receptors would also be of 332 
interest, along with sex and APOE associations with FADS and ELOVL genes which encode 333 
desaturation and elongation enzymes required for the synthesis of LC n-3 PUFAs. Differential 334 
synthesis of EPA and DHA has been reported between sexes; Pawlosky et al report greater ability 335 
of females to convert ALA to DHA through increased conversion of DPA to DHA compared to 336 
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males when consuming a beef based diet. These results were not observed when consuming a fish 337 
based diet in which the capacity to convert DPA to DHA was equal between males and females. 338 
These findings suggest LC n-3 PUFA metabolism in females may be more sensitive to dietary 339 
alterations or may be affected by hormonal regulation43. Indeed there is evidence for up-regulation 340 
of the desaturase-elongase pathway via oestrogenic actions resulting in increased conversion of 341 
ALA to EPA19 44 45 and to DHA11 13 46 indicating significant effects of female sex hormones on the 342 
metabolism of LC n-3 PUFAs. Consistent with these observations, there is evidence for an increase 343 
in DHA in relation to EPA and DPA at baseline and in response to EPA+DHA intake in females 344 
compared to males 47 48. The current analysis further reports lower concentrations of both DPA (-345 
36% lower absolute concentration in TGs) and EPA (20% lower absolute concentration in TGs) in 346 
females but does not report higher concentrations of DHA in females or find a significant effect of 347 
sex on the ratio of DPA: DHA (P >0.50, data not shown). However, these results are also in 348 
contrast to other reports describing increased concentrations of EPA and DHA in females 19 44 45. 349 
These data from the current analysis suggest investigation into associations between sex, APOE, 350 
and fatty acid synthesis enzymes and transporters would be of worthwhile to further understand the 351 
mechanisms by which these associations occur.  352 
 353 
In conclusion, we report concentrations of EPA, DPA and DHA to vary across APOE 354 
genotype and that sex is an important factor to consider when evaluating LC n-3 PUFA 355 
concentrations in these genotypic subgroups. Our results also confirm that concentrations of EPA, 356 
DPA and DHA in plasma pools are suitable population markers of oily fish consumption and show 357 
that age and sex are important contributors to the variation in EPA, DPA and DHA concentrations 358 
in plasma lipids independent of APOE genotype. These variables should be considered when 359 
interpreting LC n-3 PUFA concentrations as a marker of dietary intake and when suggesting dietary 360 
LC n-3 PUFA recommendations to ensure benefits are achieved across population subgroups. 361 
Investigation into the handling of supplemental EPA and DHA in these subgroups is to be 362 
addressed in a further publication and could provide the basis for more detailed advice. However, 363 
the aetiology and physiological significance of the interaction between sex and APOE genotype and 364 
its association with EPA, DPA and DHA status still requires further investigation.  365 
 366 
Acknowledgements 367 
The authors thank Christine Williams and Muriel Caslake for study design contributions, and 368 
Dorothy Bedford, Josephine Cooney, Frances L Napper, Lesley Farrell, Christine Gourlay, Jilly P 369 
Grew, Elaine McDonald, Elizabeth Murray, Julie Stannard, Grace Stewart, May Stewart, Philip 370 
Stewart, Elli Vastardi and Jan Luff for technical assistance. 371 
14 
 
 
 372 
Authors’ responsibilities 373 
The authors’ responsibilities were as follows: GL, CKA, JCM, CJP, PCC and AMM (the study 374 
management group) were responsible for designing the original FINGEN study and supervising all 375 
aspects of the reported work; EAM, BMK, PJC and CKA recruited and screened volunteers, carried 376 
out the intervention, collected the blood samples and collected the anthropometric, questionnaire 377 
and compliance data; HLF conducted the laboratory analysis reported herein; HLF and MI 378 
conducted statistical analysis; HLF wrote the draft of the manuscript; all authors contributed to the 379 
final version of the manuscript.  380 
 381 
Conflicts of interest 382 
PCC is an advisor to Pronova BioPharma, Aker Biomarine, Smartfish, Sancilio, Solutex, Dutch 383 
State Mines, Cargill and Danone/Nutricia. None of the other authors has any conflict to declare. 384 
  385 
15 
 
 
References 386 
1. Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr 2012;142(3):592S-99S. 387 
2. Calder PC. Functional Roles of Fatty Acids and Their Effects on Human Health. JPEN J Parenter Enteral 388 
Nutr 2015;39(1 Suppl):18S-32S. 389 
3. Djousse L, Akinkuolie AO, Wu JH, Ding EL, Gaziano JM. Fish consumption, omega-3 fatty acids and risk of 390 
heart failure: a meta-analysis. Clin Nutr 2012;31(6):846-53. 391 
4. Caslake MJ, Miles EA, Kofler BM, Lietz G, Curtis P, Armah CK, et al. Effect of sex and genotype on 392 
cardiovascular biomarker response to fish oils: the FINGEN Study. The American journal of clinical 393 
nutrition 2008;88(3):618-29. 394 
5. Calder PC. Very long-chain n-3 fatty acids and human health: fact, fiction and the future. Proc Nutr Soc 395 
2017:1-21. 396 
6. SACN. Advice on Fish Consumption: Benefits and Risks. United Kingdom: TSO; 2004. 397 
7. Penny M. Kris-Etherton, Harris WS, Appel LJ. Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and 398 
Cardiovascular Disease. Circulation 2002;106(21):2747-57. 399 
8. Browning LM, Walker CG, Mander AP, West AL, Madden J, Gambell JM, et al. Incorporation of 400 
eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing 401 
doses equivalent to typical intakes of oily fish. The American journal of clinical nutrition 402 
2012;96(4):748-58. 403 
9. Bakewell L, Burdge GC, Calder PC. Polyunsaturated fatty acid concentrations in young men and women 404 
consuming their habitual diets. Br J Nutr 2007;96(1):93. 405 
10. Crowe FL, Skeaff CM, Green TJ, Gray AR. Serum n-3 long-chain PUFA differ by sex and age in a 406 
population-based survey of New Zealand adolescents and adults. Br J Nutr 2008;99(1):168-74. 407 
11. Walker CG, Browning LM, Mander AP, Madden J, West AL, Calder PC, et al. Age and sex differences in 408 
the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans. Br J 409 
Nutr 2014;111(4):679-89. 410 
12. Thifault E, Cormier H, Bouchard-Mercier A, Rudkowska I, Paradis A-M, Garneau V, et al. Effects of Age, 411 
Sex, Body Mass Index and APOE Genotype on Cardiovascular Biomarker Response to an n-3 412 
Polyunsaturated Fatty Acid Supplementation. J Nutrigenet Nutrigenomics 2013;6(2):73-82. 413 
13. Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL. Docosahexaenoic acid concentrations are higher 414 
in women than in men because of estrogenic effects. The American journal of clinical nutrition 415 
2004;80:1167-74. 416 
14. Chouinard-Watkins R, Conway V, Minihane AM, Jackson KG, Lovegrove JA, Plourde M. Interaction 417 
between BMI and APOE genotype is associated with changes in the plasma long-chain-PUFA 418 
response to a fish-oil supplement in healthy participants. The American journal of clinical nutrition 419 
2015;102(2):505-13. 420 
15. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its 421 
use as a biomarker of dietary intake. Prog Lipid Res 2008;47(5):348-80. 422 
16. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipides from 423 
animal tissues. J Biol Chem 1956;226:497-509. 424 
17. Fisk HL, West AL, Childs CE, Burdge GC, Calder PC. The use of gas chromatography to analyze 425 
compositional changes of fatty acids in rat liver tissue during pregnancy. J Vis Exp 2014(85). 426 
18. Calder PC. Very long chain omega-3 (n-3) fatty acids and human health. Eur. J. Lipid Sci. Technol. 427 
2014;116(10):1280-300. 428 
19. Andersen LF, Solvoll K, Drevon CA. Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-429 
3 fatty acid concentrates. The American journal of clinical nutrition 1996;64:305-11. 430 
20. Harris WS, Pottala JV, Sands SA, Jones PG. Comparison of the effects of fish and fish-oil capsules on the 431 
n–3 432 
fatty acid content of blood cells and plasma phospholipids. The American journal of clinical nutrition 433 
2007;86:1621–5. 434 
21. Visioli F, Rise P, Marangoni F, Galli C. The intake of long chain omega 3 fatty acids through fish versus 435 
capsules results in greater increments of their plasma levels. Oléagineux, Corps gras, Lipides 436 
2004;11(2):116-17. 437 
16 
 
 
22. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. 438 
Clin Sci (Lond) 2004;107(1):1-11. 439 
23. Lee JH, O'Keefe JH, Lavie CJ, Harris WS. Omega-3 fatty acids: cardiovascular benefits, sources and 440 
sustainability. Nat Rev Cardiol 2009;6(12):753-8. 441 
24. Arab L. Biomarkers of Fat and Fatty Acid Intake. J. Nutr. 2003;133:9255-325. 442 
25. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, et al. Omega-3 fatty acids in cardiac 443 
biopsies from heart transplantation patients: correlation with erythrocytes and response to 444 
supplementation. Circulation 2004;110(12):1645-9. 445 
26. Plourde M, Chouinard-Watkins R, Vandal M, Zhang Y, Lawrence P, Brenna JT, et al. Plasma 446 
incorporation, apparent retroconversion and beta-oxidation of 13C-docosahexaenoic acid in the 447 
elderly. Nutr Metab (Lond) 2011;8:5. 448 
27. Rees D, Miles EA, Banerjee T, Wells SJ, Roynette CE, Wahle KW, et al. Dose-related effects of 449 
eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and 450 
older men. The American journal of clinical nutrition 2006;83:331-42. 451 
28. Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P. Docosahexaenoic acid 452 
homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence? Prostaglandins 453 
Leukot Essent Fatty Acids 2013;88(1):61-70. 454 
29. Committee TLRCPE. Plasma lipid distributions in selected North American populations: the Lipid 455 
Research Clinics Program Prevalence Study. Circulation 1979;60:427-39. 456 
30. Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, et al. Effects of age, 457 
gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B 458 
levels in the Framingham Offspring Study. J. Lipid Res. 1994;35: 779-92. 459 
31. Stahl A, Evans JG, Pattel S, Hirsch D, Lodish HF. Insulin Causes Fatty Acid Transport Protein Translocation 460 
and Enhanced Fatty Acid Uptake in Adipocytes. Developmental Cell 2002;2:477-88. 461 
32. Sorci-Thomas M, Babiak J, Rudel LL. Lecithin-Cholesterol Acyltransferase (LCAT) Catalyzes Transacylation 462 
of Intact Cholesteryl Esters. J. Biol. Chem. 1989;265(5):2665-70. 463 
33. Micallef M, Munro I, Phang M, Garg M. Plasma n-3 Polyunsaturated Fatty Acids are negatively 464 
associated with obesity. Br J Nutr 2009;102(9):1370-4. 465 
34. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty 466 
acid metabolism in obesity. J Clin Invest 1989;83(4):11681173. 467 
35. Klein-Platat, Drai J, Oujaa M, Schlienger JL, C. S. Plasma fatty acid composition is associated with the 468 
metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr. 469 
2005;82((6):):1178-84. 470 
36. Plourde M, Chouinard-Watkins R, Rioux-Perreault C, Fortier M, Dang MT, Allard MJ, et al. Kinetics of 471 
13C-DHA before and during fish-oil supplementation in healthy older individuals. The American 472 
journal of clinical nutrition 2014;100(1):105-12. 473 
37. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, H. Bryan Brewer J. Abnormal In Vivo Metabolism of 474 
Apolipoprotein E4 in Humans. The Journal of Clinical Investigation, 1986;78:815-21. 475 
38. Soerensen M, Dato S, Tan Q, Thinggaard M, Kleindorp R, Beekman M, et al. Evidence from case-control 476 
and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with 477 
human longevity. Age (Dordr) 2013;35(2):487-500. 478 
39. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, et al. Association of apolipoprotein 479 
E genotypes with lipid levels and coronary risk. Jama 2007;298(11):1300-11. 480 
40. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease 481 
genetic association studies: the AlzGene database. Nat Genet 2007;39(1):17-23. 482 
41. Chouinard-Watkins R, Rioux-Perreault C, Fortier M, Tremblay-Mercier J, Zhang Y, Lawrence P, et al. 483 
Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE 484 
epsilon4 allele. Br J Nutr 2013;110(10):1751-9. 485 
42. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, et al. Mfsd2a is a transporter for the 486 
essential omega-3 fatty acid docosahexaenoic acid. Nature 2014;509(7501):503-6. 487 
43. Pawlosky R, Hibbeln J, Lin Y, Salem N. n-3 Fatty acid metabolism in women. British Journal of Nutrition 488 
2003;90(05):993-95. 489 
17 
 
 
44. Katan MB, Deslypere JP, Angelique P. J. M. van Birgelen, Penders M, Zegwaard M. Kinetics of the 490 
incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and 491 
adipose tissue: an 18-month controlled study. J Lipid Res 1997;38:2012-22. 492 
45. Childs CE, Kew S, Finnegan YE, Minihane AM, Leigh-Firbank EC, Williams CM, et al. Increased dietary α-493 
linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination 494 
of data from a randomised, placebo-controlled, parallel study. Nutrition Journal 2014;13(113). 495 
46. Childs CE, Romeu-Nadal M, Burdge GC, Calder PC. Gender differences in the n-3 fatty acid content of 496 
tissues. Proc Nutr Soc 2008;67(1):19-27. 497 
47. Metherel AH, Armstrong JM, Patterson AC, Stark KD. Assessment of blood measures of n-3 498 
polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. 499 
Prostaglandins Leukot Essent Fatty Acids 2009;81(1):23-9. 500 
48. Patterson AC, Chalil A, Aristizabal Henao JJ, Streit IT, Stark KD. Omega-3 polyunsaturated fatty acid 501 
blood biomarkers increase linearly in men and women after tightly controlled intakes of 0.25, 0.5, 502 
and 1 g/d of EPA + DHA. Nutr Res 2015;35(12):1040-51. 503 
504 
18 
 
 
Table 1 
Median EPA, DPA, and DHA in the plasma lipid fractions and statistical significance (P) of the association of oily fish intake, sex, age, and BMI 
on absolute and relative concentrations of these LC n-3 PUFAs1  
                                                                                        EPA 
 PC NEFAs CEs TGs  PC NEFAs CEs TGs 
 (P) (P) (P) (P)  (P) (P) (P) (P) 
  % %   % %   μg/ml μg/ml    μg/ml μg/ml 
Median  1.01 0.43 0.77 0.42  15.14 0.85 14.2 2.98 
(25th, 75th percentile) (0.65, 1.57) (0.26, 0.66) (0.46, 1.10) (0.27, 0.65)   (8.74, 23.23) (0.48, 1.47) (8.45, 23.45) (1.83, 4.72) 
Oily Fish Intake2  0.055 - 0.004 <0.001  0.018 - 0.058 <0.001 
Sex  - - 0.055 -  - - - - 
Age3  0.063 - - -  0.021 - 0.019 0.034 
BMI4  - - - 0.041   - - - - 
                                                                                            DPA 
 PC NEFAs CEs TGs  PC NEFAs CEs TGs 
 (P) (P) (P) (P)  (P) (P) (P) (P) 
  % % % %   μg/ml μg/ml μg/ml μg/ml 
Median  0.78 0.31 0.07 0.33  11.87 0.62 1.34 2.32 
(25th, 75th percentile) (0.55, 0.98) (0.22, 0.44) (0.05, 0.12) (0.23, 0.47)   (7.90, 15.67) (0.42, 0.86) (0.84, 2.51) (1.31, 3.51) 
Oily Fish Intake2  0.022 - - 0.006  0.044 - - 0.016 
Sex  0.026 - - 0.043  0.054 - - <0.001 
Age3  - 0.031 - -  - - 0.007 - 
BMI4  - - - 0.006   - - - - 
                                                                                            DHA 
 PC NEFAs CEs TGs  PC NEFAs CEs TGs 
  (P) (P) (P) (P)   (P) (P) (P) (P) 
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  % % % %   μg/ml μg/ml μg/ml μg/ml 
Median  2.86 1.1 0.46 0.61  44.13 2.07 9.01 4.28 
(25th, 75th percentile) (2.08, 3.93) (0.80, 1.54) (0.32, 0.61) (0.39, 0.98)   (29.94, 57.68) (1.43, 3.18) (5.88, 12.59) (2.38, 7.19) 
Oily Fish Intake2  <0.001 <0.001 0.001 <0.001  <0.001 0.002 0.045 <0.001 
Sex  - - - -  - - - - 
Age3  0.037 - - -  0.043 - 0.039 0.050 
BMI4  - - - 0.02   - - - - 
EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; PC, phosphatidylcholine; NEFAs, non-esterified fatty 
acids; CEs, cholesteryl esters; TGs, triacyglycerol.       
1 P values obtained using log10 data in univariate general linear model analysis. Individual associations were investigated for by the addition of all 
other variables as covariates, controlling for any associations between confounding variables that may influence the dependant variable. The 
resulting P values are therefore reflective of the sole association between the variable of interest and the dependant variable.     
2 Oily fish intake: 0 portions/week, 0.1-0.99/week, 1.0-1.99/week, and 2+/week. Oily fish defined as: salmon, herring, mackerel, fresh tuna, 
sardines, kippers, and trout.          
3 Age: 20-29y, 30-39y, 40-49y, 50-59y, 60+y.            
4 BMI: Normal weight = 18-25 (kg/m2), Overweight = 25.1-30 (kg/m2) and Obese = 30.1-46 (kg/m2).       
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Table 2 
Statistical significance (P) of the associations between oily fish intake, sex, age, BMI and LC n-3 PUFAs in males and females1   
  MALES 
  PC NEFAs CEs TGs  PC NEFAs CEs TGs 
  P1 P1 P1 P1  P
1 P1 P1 P1 
    % % % %   µg/ml µg/ml µg/ml µg/ml 
EPA Oily fish intake2 - - - 0.028  0.062 0.061 - 0.008 
 Age3 - - - -  - - 0.058 0.019 
  BMI4 - - - 0.014   - - - - 
DPA Oily fish intake2 - - NS -  0.066 0.026 - - 
 Age3 - - 0.068 -  - - 0.012 - 
  BMI4 - - - -   - - - - 
DHA Oily fish intake2 0.003 0.023 0.016 -  0.002 0.014 - - 
 Age3 - - 0.011 -  - 0.024 0.005 - 
  BMI4 - - - -   - - - - 
  FEMALES 
  PC NEFAs CEs TGs  PC NEFAs CEs TGs 
  P1 P1 P1 P1  P
1 P1 P1 P1 
    % % % %   µg/ml µg/ml µg/ml µg/ml 
EPA Oily fish intake2 0.004 - 0.009 <0.001  0.003 - - <0.001 
 Age3 0.04 - - -  0.039 - - 0.006 
  BMI4 - - - -   - 0.052 - 0.006 
DPA Oily fish intake2 - - - 0.008  - - - 0.067 
 Age3 - - - -  - - - - 
  BMI4 - - - -   - - - - 
DHA Oily fish intake2 0.001 0.001 0.003 <0.001  <0.001 0.048 - 0.001 
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 Age3 0.035 - - -  0.047 - - 0.032 
  BMI4 - - - -   - 0.010 - - 
EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; PC, phosphatidylcholine; NEFAs, non-esterified fatty 
acids; CEs, cholesteryl esters; TGs, triacyglycerol.  
1 P values obtained using log10 data in univariate general linear model analysis. Individual associations were investigated for by the addition of all 
other variables as covariates, controlling for any associations between confounding variables that may influence the dependant variable. The 
resulting P values are therefore reflective of the sole association between the variable of interest and the dependant variable.     
2 Oily fish intake: 0 portions/week, 0.1-0.99/week, 1.0-1.99/week, and 2+/week. Oily fish defined as: salmon, herring, mackerel, fresh tuna, 
sardines, kippers, and trout.          
3 Age: 20-29y, 30-39y, 40-49y, 50-59y, 60+y.            
4 BMI: Normal weight = 18-25 (kg/m2), Overweight = 25.1-30 (kg/m2) and Obese = 30.1-46 (kg/m2).        
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TABLE 3 
Blood cholesterol (mmol/l) concentration according to sex, age, BMI, APOE genotype and 
oily fish intake 
  TC HDLC LDLC 
  Mean SEM Mean SEM Mean SEM 
Male 5.16 0.08 1.26 0.02 3.34 0.07 
Female 5.16 0.08 1.61 0.03 3.17 0.07 
1P NS  <0.001  NS  
Age group  
 
 
 
  
20-29y 4.39 0.14 1.46 0.05 2.56 0.13 
30-39y 4.68 0.1 1.34 0.04 2.93 0.1 
40-49y 5.34 0.11 1.47 0.04 3.41 0.09 
50-59y 5.57 0.1 1.45 0.05 3.62 0.09 
60+y 5.59 0.13 1.49 0.06 3.52 0.1 
2P <0.001  NS  <0.001  
3BMI group       
Normal weight 4.91 0.08 1.57 0.03 2.98 0.07 
Overweight 5.33 0.08 1.34 0.03 3.43 0.07 
Obese 5.63 0.18 1.20 0.05 3.77 0.17 
2P <0.001  <0.001  <0.001  
APOEgenotype4  
 
 
 
  
E2 4.71 0.09 1.54 0.04 2.76 0.08 
E3 5.19 0.1 1.43 0.04 3.31 0.08 
E4 5.46 0.08 1.37 0.03 3.57 0.07 
1P <0.001  0.006  <0.001  
Oily fish intake5  
 
 
 
  
0/wk 4.9 0.12 1.41 0.04 3.11 0.1 
0.1-0.99/wk 5.21 0.09 1.44 0.03 3.25 0.07 
1-1.99/wk 5.3 0.12 1.48 0.05 3.38 0.1 
2+/wk 5.16 0.15 1.41 0.07 3.28 0.15 
2P NS  NS  NS NS 
TC, Total cholesterol; HDLC, high density lipoprotein cholesterol; LDLC, low density 
lipoprotein cholesterol.  
1P values obtained from one-way ANOVA model.      
2 P values obtained from Pearson's correlation model.      
3 BMI: Normal weight = 18-25 (kg/m2), Overweight = 25.1-30 (kg/m2) and Obese = 30.1-46 
(kg/m2). 
4 APOE genotype: E2 (E2/E2 and E2/E3), E3 (E3/E3), and E4 (E3/E4 and E4/E4) . 
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5 Oily fish defined as: salmon, herring, mackerel, fresh tuna, sardines, kippers, and trout. 
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FIGURE 1 Absolute concentrations (µg/ml) of eicosapentaenoic acid (EPA) in 
phosphatidylcholine (PC), non-esterified fatty acids (NEFAs), cholesteryl esters (CEs) and 
triacylglycerols (TGs) lipid fractions in male and female subjects according to APOE 
genotype. Distribution of participants in each APOE allele group are as follows; PC: Males: 
E2/E2 = 1, E2/E3 = 32, E3/E3 = 40, E3/E4 = 51, and E4/E4 = 2. Total: 126. PC: Females: 
E2/E2 = 3, E2/E3 = 39, E3/E3 = 44, E3/E4 = 43, and E4/E4 = 10. Total: 139. NEFAs: Males: 
E2/E2 = 2, E2/E3 = 29, E3/E3 = 45, E3/E4 = 50, and E4/E4 = 2. Total: 128. NEFAs: 
Females: E2/E2 = 3, E2/E3 = 42, E3/E3 = 44, E3/E4 = 45, and E4/E4 = 10. Total: 144. CEs: 
Males: E2/E2 = 2, E2/E3 = 33, E3/E3 = 50, E3/E4 = 52, and E4/E4 = 2. Total: 139. CEs: 
Females: E2/E2 = 3, E2/E3 = 44, E3/E3 = 48, E3/E4 = 49, and E4/E4 = 10. Total: 154. TGs: 
Males: E2/E2 = 2, E2/E3 = 32, E3/E3 = 50, E3/E4 = 53, and E4/E4 = 2. Total: 139. TGs: 
Females: E2/E2 = 3, E2/E3 = 45, E3/E3 = 49, E3/E4 = 48, and E4/E4 = 10. Total: 155. * P < 
0.050, and ** P > 0.050 but < 0.060. P values were obtained using log-10 data in univariate 
general linear model (GLM) analysis controlling for covariates (age, BMI, and oily fish 
intake). Where there was a significant association with APOE genotype, significance between 
specific APOE alleles was assessed using parameter estimates obtained from the GLM 
results. 
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FIGURE 2 Absolute concentrations (µg/ml) of docosapentaenoic acid (DPA) in 
phosphatidylcholine (PC), non-esterified fatty acids (NEFAs), cholesteryl esters (CEs) and 
triacylglycerols (TGs) lipid fractions in male and female subjects according to APOE 
genotype. Distribution of participants in each APOE allele group are as follows; PC: Males: 
E2/E2 = 1, E2/E3 = 32, E3/E3 = 40, E3/E4 = 51, and E4/E4 = 2. Total: 126. PC: Females: 
E2/E2 = 3, E2/E3 = 39, E3/E3 = 44, E3/E4 = 43, and E4/E4 = 10. Total: 139. NEFAs: Males: 
E2/E2 = 2, E2/E3 = 29, E3/E3 = 45, E3/E4 = 50, and E4/E4 = 2. Total: 128. NEFAs: 
Females: E2/E2 = 3, E2/E3 = 42, E3/E3 = 44, E3/E4 = 45, and E4/E4 = 10. Total: 144. CEs: 
Males: E2/E2 = 2, E2/E3 = 33, E3/E3 = 50, E3/E4 = 52, and E4/E4 = 2. Total: 139. CEs: 
Females: E2/E2 = 3, E2/E3 = 44, E3/E3 = 48, E3/E4 = 49, and E4/E4 = 10. Total: 154. TGs: 
Males: E2/E2 = 2, E2/E3 = 32, E3/E3 = 50, E3/E4 = 53, and E4/E4 = 2. Total: 139. TGs: 
Females: E2/E2 = 3, E2/E3 = 45, E3/E3 = 49, E3/E4 = 48, and E4/E4 = 10. Total: 155. * P < 
0.050. ** P > 0.050 but < 0.070. P values were obtained using log-10 data in univariate 
general linear model (GLM) analysis controlling for covariates (age, BMI, and oily fish 
intake). Where there was a significant association with APOE genotype, significance between 
specific APOE alleles was assessed using parameter estimates obtained from the GLM 
results. 
 
FIGURE 3 Absolute concentrations (µg/ml) of docosahexaenoic acid (DHA) in 
phosphatidylcholine (PC), non-esterified fatty acids (NEFAs), cholesteryl esters (CEs) and 
triacylglycerols (TGs) lipid fractions in male and female subjects according to APOE 
genotype. Distribution of participants in each APOE allele group are as follows; PC: Males: 
E2/E2 = 1, E2/E3 = 32, E3/E3 = 40, E3/E4 = 51, and E4/E4 = 2. Total: 126. PC: Females: 
E2/E2 = 3, E2/E3 = 39, E3/E3 = 44, E3/E4 = 43, and E4/E4 = 10. Total: 139. NEFAs: Males: 
E2/E2 = 2, E2/E3 = 29, E3/E3 = 45, E3/E4 = 50, and E4/E4 = 2. Total: 128. NEFAs: 
Females: E2/E2 = 3, E2/E3 = 42, E3/E3 = 44, E3/E4 = 45, and E4/E4 = 10. Total: 144. CEs: 
Males: E2/E2 = 2, E2/E3 = 33, E3/E3 = 50, E3/E4 = 52, and E4/E4 = 2. Total: 139. CEs: 
Females: E2/E2 = 3, E2/E3 = 44, E3/E3 = 48, E3/E4 = 49, and E4/E4 = 10. Total: 154. TGs: 
Males: E2/E2 = 2, E2/E3 = 32, E3/E3 = 50, E3/E4 = 53, and E4/E4 = 2. Total: 139. TGs: 
Females: E2/E2 = 3, E2/E3 = 45, E3/E3 = 49, E3/E4 = 48, and E4/E4 = 10. Total: 155. * P = 
0.021. P values were obtained using log-10 data in univariate general linear model (GLM) 
analysis controlling for covariates (age, BMI, and oily fish intake). Where there was a 
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significant association with APOE genotype, significance between specific APOE alleles was 
assessed using parameter estimates obtained from the GLM results.  
 
